Novo Nordisk A/S ADR buy melinda
Start price
17.01.17
/
50%
€32.79
Target price
24.04.17
€33.37
Performance (%)
2.29%
End price
24.04.17
€32.94
Summary
This prediction ended on 24.04.17 with a price of €32.94. The BUY prediction by melinda finished with a performance of 2.29%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S ADR | 1.235% | 1.235% | -33.871% | 45.735% |
iShares Core DAX® | -0.531% | 3.824% | 15.862% | 16.424% |
iShares Nasdaq 100 | 2.338% | 3.067% | 21.901% | 35.414% |
iShares Nikkei 225® | 1.332% | 5.933% | 12.099% | -0.322% |
iShares S&P 500 | 1.181% | 3.042% | 22.103% | 38.834% |
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk (NVO) erhält FDA Orphan-Drug-Status von Diabetes Combo
folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€43.06
01.09.17
01.09.17
€49.61
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.74
01.09.17
01.09.17
€55.00
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.95
06.07.17
06.07.17
€45.10
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17